Article info
Diagnostics
Short report
Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer
- Correspondence to Dr Conxi Lázaro, Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, 08908 Catalunya, Spain; clazaro{at}iconcologia.net; Dr Bernat Gel; bgel{at}igtp.cat
Citation
Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer
Publication history
- Received July 23, 2020
- Revised September 23, 2020
- Accepted September 24, 2020
- First published November 20, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.